PJ Online | News: Influenza vaccination cost-effective for healthy young adults
The Pharmaceutical Journal
Influenza vaccination cost-effective for healthy young adults
Vaccinating healthy younger adults against influenza is worthwhile, say American researchers. Using a computer model the researchers found that prevention and treatment strategies which included vaccination had an overall saving of about $30 (?19) each compared with no vaccination and no treatment with antivirals. Non-vaccination became optimal only for mild influenza seasons (Annals of Internal Medicine 2002;137:225).
Citation: The Pharmaceutical Journal URI: 20007510
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com